Search / Trial NCT06617585

The Role of CircDENND4C in Epithelial Ovarian Cancer

Launched by ASSIUT UNIVERSITY · Sep 26, 2024

Trial Information

Current as of October 07, 2024

Not yet recruiting

Keywords

Description

epithelial OC (EOC), the most common form of OC, accounts for 90% of all OC cases \[2\]. EOC has the highest mortality among all gynecologic tumors and poses a serious threat to women's life \[3\].herefore, early clinical diagnosis is crucial. Commonly used laboratory indicators for OC diagnosis

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • - patients at South Egypt Cancer institute and Recently diagnosed ovarian cancer patients 2. Patients not went to surgery.
  • Exclusion Criteria:
  • * . Patients receive any anti-cancer therapy. 2. Patients diagnosed with other concomitante cancer or chronic disease

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0